Last updated: Oct 9, 2026, 12:00 AM

Prelude Therapeutics Inc Exchange (NASDAQ, USD)

PRLD

3.88
+0.05 (+1.31%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
169.44%
3 year return (CAGR)
11.75%
5 year return (CAGR)
-34.11%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
252.49M
Price/Sales
11.26
Ent value
281.79M
Price/Book
1.89
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-22.29%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open3.77
Daily high3.95
Daily low3.67
Daily Volume423K
All-time high91.68
1y analyst estimate9.20
Beta0.96
EPS (TTM)-0.61
Dividend per share0.00
Ex-div date-
Next earnings date18 Mar 2026

Ready to capitalize on Prelude Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
PRLDS&P500
Current price drop from All-time high-95.77%-0.66%
Highest price drop-99.33%-56.47%
Date of highest drop8 Apr 20259 Mar 2009
Avg drop from high-85.68%-10.67%
Avg time to new high63 days12 days
Max time to new high1422 days1805 days